Quotient Sciences Recognized as a Winner of 2025 CDMO Leadership Awards
Read More136 - 140 of 154 results
Tufts Center for the Study of Drug Development (CSDD) today published a white paper sharing study results that indicate Quotient Sciences’ Translational Pharmaceutics® platform reduces development times by more than 12 months and lowers R&a...
Learn more
An accomplished leader in the pharmaceutical industry with over 35 years’ experience, Claes Glassell has been appointed as non‐executive chairman of the Quotient Sciences board of directors. Glassell has held numerous leadership positions, ...
Learn moreQuotient Sciences and global investment firm Permira announced that a company backed by the Permira Funds has signed a definitive agreement to acquire a majority stake in Quotient Sciences.
Learn more
Quotient Sciences (“Quotient”), a leading drug development services and manufacturing organization, is pleased to announce that its Vice President of Pharmaceutical Sciences, Andy Lewis, has been appointed as Secretary of the Controlled Rel...
Learn moreQuotient Sciences announced that it has received a Transatlantic Growth Award at a ceremony hosted by BritishAmerican Business in London.
Learn more
